Literature DB >> 32233152

Subthreshold Micropulse Yellow Laser (577 nm) for Idiopathic Macular Telangiectasia Type 1 Resistant to Intravitreal Injection.

Yong Koo Kang1, Han Sang Park2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32233152      PMCID： PMC7105782          DOI： 10.3341/kjo.2019.0071

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN： 1011-8942


× No keyword cloud information.
  5 in total

1.  Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years.

Authors:  Yang Jae Kim; Si Yeol Kim; Seungmin Ha; Daruchi Moon; San Seong; Oh Woong Kwon; Han Sang Park
Journal:  Eye (Lond)       Date:  2019-01-04       Impact factor: 3.775

2.  Idiopathic macular telangiectasia.

Authors:  Lawrence A Yannuzzi; Anne M C Bardal; K Bailey Freund; Kuan-Jen Chen; Chiara M Eandi; Barbara Blodi
Journal:  Arch Ophthalmol       Date:  2006-04

3.  Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors:  Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

4.  EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.

Authors:  Laura Kowalczuk; Alexandre Matet; Ali Dirani; Alejandra Daruich; Aude Ambresin; Irmela Mantel; Richard F Spaide; Natacha Turck; Francine Behar-Cohen
Journal:  Retina       Date:  2017-12       Impact factor: 4.256

5.  Nondamaging Retinal Laser Therapy: Rationale and Applications to the Macula.

Authors:  Daniel Lavinsky; Jenny Wang; Philip Huie; Roopa Dalal; Seung Jun Lee; Dae Yeong Lee; Daniel Palanker
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-05-01       Impact factor: 4.799
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.